Page last updated: 2024-10-18

dihydroxyacetone phosphate and Zellweger Syndrome

dihydroxyacetone phosphate has been researched along with Zellweger Syndrome in 1 studies

Dihydroxyacetone Phosphate: An important intermediate in lipid biosynthesis and in glycolysis.
dihydroxyacetone phosphate : A member of the class of glycerone phosphates that consists of glycerone bearing a single phospho substituent.

Zellweger Syndrome: An autosomal recessive disorder due to defects in PEROXISOME biogenesis which involves more than 13 genes encoding peroxin proteins of the peroxisomal membrane and matrix. Zellweger syndrome is typically seen in the neonatal period with features such as dysmorphic skull; MUSCLE HYPOTONIA; SENSORINEURAL HEARING LOSS; visual compromise; SEIZURES; progressive degeneration of the KIDNEYS and the LIVER. Zellweger-like syndrome refers to phenotypes resembling the neonatal Zellweger syndrome but seen in children or adults with apparently intact peroxisome biogenesis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Okamoto, H1
Suzuki, Y1
Shimozawa, N1
Yajima, S1
Masuno, M1
Orii, T1

Other Studies

1 other study available for dihydroxyacetone phosphate and Zellweger Syndrome

ArticleYear
Transformation and characterization of mutant human fibroblasts defective in peroxisome assembly.
    Experimental cell research, 1992, Volume: 201, Issue:2

    Topics: Acyltransferases; Adrenoleukodystrophy; Cell Line, Transformed; Dihydroxyacetone Phosphate; Fatty Ac

1992